Healthcare

The Canadian Foundation for Women’s Health (CFWH) Launches Comprehensive Effort to Combat Maternal Morbidity and Mortality

As Canada's maternal health suffers from ongoing deficiencies, the foundation urges immediate prevention and intervention with a multifaceted approachOTTAWA, July…

6 months ago

Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment

DALLAS, July 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

6 months ago

Spinogenix Announces Enrollment is Open for its Phase 2 Clinical Trial of SPG601 in Fragile X Syndrome

U.S. FDA has granted Orphan Drug Designation to SPG601 for the Treatment of Fragile X Syndrome SPG601 is a novel…

6 months ago

Inovalon Launches Provider Market Insights To Empower Life Sciences Organizations With Superior Market Data

SaaS Analytics Solution Provides Life Sciences Insight Into Brand Performance, Provider Engagement, and Patient OutcomesBOWIE, Md., July 23, 2024 (GLOBE…

6 months ago

Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity

-- LB54640 has shown targeted effect on MC4R without hyperpigmentation -- BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.…

6 months ago

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies

Collaboration aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation…

6 months ago

180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the…

6 months ago

Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…

6 months ago

Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology

RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of…

6 months ago